Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sodium channel blockers for neuroprotection in multiple sclerosis.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
The signal intensity ratio of the optic nerve to ipsilateral frontal white matter is of value in the diagnosis of acute optic neuritis.
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.
Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Charles bonnet syndrome after herpes simplex encephalitis.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Deep brain stimulation for pain.
Neurologic complications of vaccinations.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Serial magnetic resonance imaging representation in a Baló's concentric sclerosis.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Pages
« first
‹ previous
…
684
685
686
687
688
689
690
691
692
…
next ›
last »